That was it PharmaCielo
The acquisition was first announced in June when it was proposed Creso Pharma be acquired at 63 cents per share via scheme of arrangement. Creso Pharma shareholders were to receive 0.0775 PharmaCielo shares for every Creso Pharma share held, which represented a value of AU$0.63 based on the 3-day volume weighted average price of PharmaCielo shares. At the time, PharmaCielo shares were trading at CA$7.61 and PharmaCielo Ltd had a market capitalisation of CA$675 million. Since then shares in PharmaCielo have plunged to CA$3.67. It has been a difficult year for Creso Pharma, which has seen its share price plunge from highs of over 50 cents in July to 20 cents currently.
Ha ha they tanked too check their price.
- Forums
- ASX - By Stock
- ME1
- Ann: Consolidation/Split - ME1
Ann: Consolidation/Split - ME1, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ME1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $924.8K |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $1.218K | 1.217M |
Featured News
ME1 (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online